SCD1 Inhibitor MTI-301 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: MTI-301; MTI301; MTI 301; Stearoyl-CoA Desaturase 1 Inhibitor MTI-301; SSI-4; SSI4; SSI 4; ); 2-{[4-(2-Chlorophenoxy)piperidine-1-carbonyl]amino}-N-methylpyridine-4-carboxamide

Filter by location:

Jacksonville, Florida1 trial

MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid Cancers

Mayo Clinic in Florida

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.